Medicus Pharma Ownership | Who Owns Medicus Pharma?
Medicus Pharma Ownership Summary
Medicus Pharma is owned by 13.42% institutional investors, 12.83% insiders, and 73.75% retail investors. Interchange capital partners is the largest institutional shareholder, holding 9.62% of MDCX shares. Abante Quant Value FI is the top mutual fund, with 0.22% of its assets in Medicus Pharma shares.
MDCX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Medicus Pharma | 13.42% | 12.83% | 73.75% |
| Sector | Healthcare Stocks | 35.56% | 12.08% | 52.36% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Interchange capital partners | 1.66M | 9.62% | $6.18M |
| Bryn mawr trust | 51.24K | 0.30% | $23.52K |
| May hill capital | 50.62K | 0.29% | $23.24K |
| Commonwealth equity services | 48.14K | 0.28% | $22.10K |
| Citadel advisors | 17.82K | 0.10% | $8.18K |
| Lpl financial | 15.61K | 0.09% | $7.17K |
| Marathon capital management | 15.50K | 0.09% | $7.12K |
| Stonex group | 15.17K | 0.09% | $6.96K |
| Smithfield trust | 11.48K | 0.07% | $5.00K |
| Advisor group | 8.50K | 0.05% | $3.91K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Interchange capital partners | 1.66M | 1.95% | $6.18M |
| May hill capital | 50.62K | 0.01% | $23.24K |
| Marathon capital management | 15.50K | 0.00% | $7.12K |
| Bryn mawr trust | 51.24K | 0.00% | $23.52K |
| Stonex group | 15.17K | 0.00% | $6.96K |
| Smithfield trust | 11.48K | 0.00% | $5.00K |
| Jane street group | - | - | - |
| Advisor group | 8.50K | - | $3.91K |
| Tower research capital llc (trc) | - | - | - |
| Virtu financial | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Interchange capital partners | 1.66M | 1.95% | 75.00K |
| Commonwealth equity services | 48.14K | - | 19.65K |
| Citadel advisors | 17.82K | - | 17.82K |
| Lpl financial | 15.61K | - | 15.61K |
| Marathon capital management | 15.50K | 0.00% | 15.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -1.81M |
| Private advisor group | - | - | -240.06K |
| Virtu financial | - | - | -74.05K |
| Jane street group | - | - | -60.34K |
| Ubs group | - | - | -40.44K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Citadel advisors | 17.82K | - | 17.82K | $8.18K |
| Marathon capital management | 15.50K | 0.00% | 15.50K | $7.12K |
| Stonex group | 15.17K | 0.00% | 15.17K | $6.96K |
Sold Out
| Holder | Change |
|---|---|
| Tower research capital llc (trc) | -121.00 |
| Dagco | -349.00 |
| Hazlett, burt & watson | -425.00 |
| Larson financial group | -1.00K |
| Brave asset management | -10.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 20 | -4.76% | 2,319,481 | -41.12% | 13 | 2.58% | 13 | -7.14% | 3 | 200.00% |
| Dec 31, 2025 | 21 | 5.00% | 3,939,518 | 85.87% | 22 | 17.61% | 14 | 40.00% | 1 | -80.00% |
| Sep 30, 2025 | 20 | -4.76% | 2,119,467 | -3.92% | 11 | 4.77% | 10 | -47.37% | 5 | 400.00% |
| Jun 30, 2025 | 21 | 200.00% | 2,206,052 | -27.71% | 15 | 2.48% | 19 | 171.43% | 1 | - |
| Mar 31, 2025 | 7 | 133.33% | 3,051,629 | 102.99% | 24 | 10.21% | 7 | 133.33% | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Abante Quant Value FI | 123.48K | 0.22% | 49.24K |
| iShares Micro-Cap ETF | 34.56K | 0.06% | - |
| Fidelity Nasdaq Composite Index | 3.75K | 0.01% | - |
| 1290 VT Micro Cap K | 2.74K | 0.00% | - |
| Wellington CIF Micro Cap Equity | 92.00 | 0.00% | -6.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 20, 2025 | VELOCITY FUND PARTNERS, LP | - | Sell | $578.94K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | 1 |
MDCX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools